New year’s resolutions are always a good way to kick off the year. The new year is upon us and as usual, we have a clean slate to work with. What will you do with it? Here are my suggestions for top 5 work-related resolutions for 2021.
Tag: Massachusetts Electronic Prescribing
Post
Happy New Year!
Happy New Year! As we leave 2020 in the rear-view mirror, we look ahead to all the new possibilities the New Year brings. As is the case every year, we have ongoing projects and exciting plans for some new additions in the coming months. Every year begins full of hope and promise, and we would like to wish you great success in achieving your dreams and goals this year.
Post
Merry Christmas!
Merry Christmas! 2020 has been a difficult and challenging year for everyone, but we all have so much to be thankful for. At OctariusRx we are thankful for all the clients who have been with us for years, as well as the new partners who joined us in 2020. We are also thankful for our entire team, who works tirelessly to provide exceptional services…we could not do it without them. Thank you to everyone who has helped make this a successful year. We appreciate the support and trust we have from our clients, team members, family, and friends.
Post
The Year in Review: 2020
As we approach 2021, I take a few moments to look back at some of the biggest stories impacting us this year. Each year is unique and has its own challenges. When it comes to challenges, we all realize 2020 is unprecedented and will stand out in our memories…often for the wrong reasons. As a consultant pharmacist, I get asked for advice daily. In this post, I discuss some of the topics that generated the most questions and drew the most attention from our clients. This is a small sample of topics we helped our partners with this year.
Post
Are you ready for Electronic Prescribing requirements?
Are you ready for electronic prescribing requirements? They come into effect soon so make sure you are prepared. Beginning January 1, 2021, all prescriptions for controlled substances and medical devices in Massachusetts must be issued electronically unless covered by an exception.
Post
Can You Spot the Patient Safety Issue?
Medication competency and your consultant pharmacist are two things that should go hand-in-hand. We all know that ongoing education and assessments are required to demonstrate staff competency and safe medication management is no exception. How are you assessing your staff? Can your consultant pharmacist help?
Post
Working with a Consultant Pharmacist to Open an ASC
Working with a Consultant Pharmacist to Open an ASC is something every organization should consider. Opening an ASC requires extensive organization and collaboration between various experts. Involving a highly qualified consultant pharmacist among your team of expert advisors will help ensure patient safety, regulatory compliance, and survey success. Are you considering opening an ASC? Have you gathered all the necessary advisors to ensure your grand opening is as seamless as possible?
Post
Look-alike-sound-alike Risks with Flu Vaccine and Insulin
Look-alike-sound-alike risks with flu vaccine and insulin may not be something you normally consider, but the risk of patient harm is extremely high. Do you have a facility specific look-alike-sound-alike list? Is it updated annually and posted in areas of medication administration? As a consultant pharmacist, I have the following five suggestions for minimizing risks and increasing patient safety.
Post
Medication Competency and Your Consultant Pharmacist
Medication competency and your consultant pharmacist are two things that should go hand-in-hand. We all know that ongoing education and assessments are required to demonstrate staff competency and safe medication management is no exception. How are you assessing your staff? Can your consultant pharmacist help?
Post
The FDA Recommends Prescribers Discuss Naloxone when Prescribing Opioids
The FDA recommends prescribers discuss naloxone when prescribing opioids or medications to treat opioid use disorder (OUD). In a recent Drug Safety Communication posted on July 23, 2020, the FDA made the recommendations about naloxone in an effort to reduce the risk of death from opioid overdose. Do you know what the FDA is recommending? What steps do you need to take as a prescriber?